Semaglutide (sold under the brand names Wegovy or Ozempic) is an FDA-approved weight loss medication that falls under the category of GLP-1 receptor agonists
This rapid expansion in use (with nearly 12% of Americans now having tried GLP-1 medications) has brought with it concerning reports of severe side effects that manufacturers allegedly failed to adequately disclose, forming the basis of thousands of lawsuits now consolidated in federal court
Why GLP 1 Medications Cause Constipation and How to Find Relief GLP 1 receptor agonists like semaglutide , tirzepatide , Ozempic , Wegovy , and Mounjaro have become powerful tools for weight loss and metabolic health
Los datos de farmacovigilancia recopilados hasta la fecha no han revelado patrones preocupantes de cncer asociados con su uso, con la excepcin de la advertencia especfica sobre carcinoma medular de tiroides basada en estudios preclnicos en roedores
What side effects might slow my weight loss progress
Ongoing cortisol can blunt satiety hormones like GLP-1, so it is harder to feel satisfied
